ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,231Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 79

$1.02M Total Retail Price of All Prescriptions

Rank: 10 out of 79

435 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 435 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

29% of this provider’s 435 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 15,823 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
FUROSEMIDE 885 789 1 4
LEVOTHYROXINE SODIUM 621 573 2 1
POTASSIUM CHLORIDE 569 514 3 11
NAMENDA 541 503 4 9
HYDROCODONE-ACETAMINOPHEN 509 420 S3 5 5
SIMVASTATIN 485 408 6 3
DONEPEZIL HCL 455 440 7 8
LISINOPRIL 410 381 8 2
METOPROLOL TARTRATE 409 353 9 10
METFORMIN HCL 374 335 10 13
MIRTAZAPINE 366 334 11 15
QUETIAPINE FUMARATE 362 304 12 20
SERTRALINE HCL 343 311 13 16
OMEPRAZOLE 333 277 14 7
CITALOPRAM HBR 321 287 15 18
TRAMADOL HCL 302 267 16 17
RANITIDINE HCL 300 261 17 33
GABAPENTIN 285 213 18 12
AMLODIPINE BESYLATE 275 256 19 6
WARFARIN SODIUM 275 252 19 14
MELOXICAM 258 252 21 52
CARVEDILOL 209 175 22 21
ISOSORBIDE MONONITRATE ER 191 176 23 59
RAMIPRIL 180 140 24 47
METOPROLOL SUCCINATE 176 152 25 23
SEROQUEL 152 132 26 51
GLIMEPIRIDE 151 151 27 77
ATORVASTATIN CALCIUM 148 146 28 30
PRAVASTATIN SODIUM 147 141 29 38
RISPERIDONE 141 123 30 24
ZOLPIDEM TARTRATE 140 118 31 28
ATENOLOL 138 121 32 45
TAMSULOSIN HCL 135 129 33 36
ALENDRONATE SODIUM 135 135 33 32
CLOPIDOGREL 129 102 35 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 127 122 36 53
TRAZODONE HCL 126 100 37 19
KLOR-CON M10 123 123 38 68
LOVASTATIN 115 111 39 102
ESCITALOPRAM OXALATE 114 112 40 25
ALBUTEROL SULFATE 112 101 41 50
PANTOPRAZOLE SODIUM 109 99 42 37
LANTUS 105 89 43 26
CLONIDINE HCL 95 82 44 49
ABILIFY 95 61 44 74
DIVALPROEX SODIUM 93 78 46 29
OLANZAPINE 88 87 47 57
NYSTATIN 84 78 48 80
DILTIAZEM 24HR CD 81 72 49 163
SULFAMETHOXAZOLE-TRIMETHOPRIM 81 63 49 81
ROPINIROLE HCL 80 69 51 109
NOVOLIN R 79 68 52 39
FINASTERIDE 79 79 52 97
CYMBALTA 78 60 54 27
NIFEDIPINE ER 76 75 55 113
EXELON 74 73 56 41
PREDNISONE 72 55 57 54
DIGOXIN 70 43 58 42
LAMOTRIGINE 68 35 59 235
DOXYCYCLINE HYCLATE 68 62 59 132
IPRATROPIUM-ALBUTEROL 68 65 59 71
LEVEMIR 67 65 62 99
GEMFIBROZIL 67 55 62 133
KLOR-CON M20 66 51 64 63
ZIPRASIDONE HCL 64 41 65 157
POLYETHYLENE GLYCOL 3350 62 60 66 58
FAMOTIDINE 62 48 66 60
ALLOPURINOL 59 58 68 65
BACLOFEN 59 21 68 84
FLUTICASONE PROPIONATE 57 57 70 47
OXYBUTYNIN CHLORIDE ER 57 57 70 110
BENZTROPINE MESYLATE 57 35 R 70 72
HYDROCHLOROTHIAZIDE 56 44 73 22
DIOVAN 55 55 74 56
CIPROFLOXACIN HCL 53 48 75 79
PROMETHAZINE HCL 53 52 R 75 76
PLAVIX 52 38 77 46
CYCLOBENZAPRINE HCL 51 27 R 78 95
TRAVATAN Z 50 50 79 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.